Treatment of chronic hepatitis B in children with prednisolone withdrawal followed by recombinant interferon alpha

Yonsei Medical Journal

Volumn 39, Issue 4, 1998, Pages 309-316

  Kim, Hyo Sin ^a   Kim, Je Woo ^a   Chung, Ki Sup ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

Children; Chronic hepatitis B; Interferon; Prednisolone

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA2A INTERFERON; ASPARTATE AMINOTRANSFERASE; HEPATITIS B(E) ANTIGEN; INTERMAX A; PREDNISOLONE; RECOMBINANT ALPHA INTERFERON; UNCLASSIFIED DRUG; VIRUS DNA;

ADOLESCENT; ARTICLE; CHILD; CHRONIC HEPATITIS; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG WITHDRAWAL; FEMALE; HEPATITIS B; HUMAN; LIVER BIOPSY; MALE; ORAL DRUG ADMINISTRATION; SEROCONVERSION;

EID: 7344265055     PISSN: 05135796     EISSN: None     Source Type: Journal    
DOI: 10.3349/ymj.1998.39.4.309     Document Type: Article

References (24)

1. Beasley RP, Lee GY, Roan CH, Hwang LY, Lan CC, Hwang FY: Prevention of perinatally transmitted hepatitis B virus infection with hepatitis B immunoglobulin and hepatitis B vaccine. Lancet 2: 1099-1102, 1983
2. Burczynska B, Madalinski K: The value of quantitative measurement of HBeAg and HBsAg before IFN alpha treatment of chronic hepatitis B in children. J Hepatol 21: 1097-1102, 1994
3. Chang MH, Hwang LY, Hsu HC, Lee CY, Beasley RP: Prospective study of asymptomatic HBsAg carrier children infected in the perinatal period: clinical and liver histologic studies. Hepatology 8: 374-377, 1988
4. Giacchino R, Main J, Timitilli A, Giambartolomeni G, Facco F, Cirillo C, Jacina MR, Brook MG, Callea F, Kariayannis P, Terragna A, Thomas HC: Dual-centre, double-blind, randomized trial of lymphoblastoid interferon alpha with or without steroid pretreatment in children with chronic hepatitis B. Liver 15: 143-148, 1995
5. Greenberg HB, Pallard RB, Lutwick LI, Gregory PB, Robinson WS, Merigan TC: Effect of human leukocyte interferon on hepatitis virus infection in patients with chronic active hepatitis. N Engl J Med 295: 517-522, 1976
6. Gregorio GV, Jara P, Hierro L, Diaz C, de la Vega A, Vegnente A, Iorio R, Bortolotti F, Crivellaro C, Zancan L, Daniels H, Portmann B, Mieli-Vergani G: Lymphoblastoid interferon alfa with or without steroid pretreatment in children with chronic hepatitis B: a multicenter controlled trial. Hepatology 23: 700-707, 1996
7. Hoofnagle JH, Peters M, Mullen KD, Jones DB, Rustgi V, Di Bisceglie A, Hallahan C, Park Y, Meschievitz C, Jones EA: Randomized, controlled trial of recombinant human alpha interferon in patients with chronic hepatitis B. Gastroenterology 95: 1318-1325, 1988
8. Jeong IS, Chung KS: The therapeutic effect of interferon-alpha treatment in children with chronic hepatitis B. J Korean Pediatr Soc 40: 955-964, 1997
9. Krogsgaard K: Does corticosteroid pretreatment enhance the effect of alpha interferon treatment in chronic hepatitis B? J Hepatol 20: 159-162, 1994
10. Lai CL, Lin HJ, Yeoh EK, Lik ASF, Wu PC, Yeung CY: Placebo-controlled trial of recombinant alfa-2-interferon in Chinese HBsAg carrier children. Lancet ii: 870-880, 1987
11. Lok ASF, Lai CL, Wu PC, Lan JYN, Leung EKY, Wong LSK: Treatment of chronic hepatitis B with interferon: experience in Asian patients. Semin Liver Dis 9: 249-253, 1989
12. Mora I, Porres JC, Bartolome J: Changes of hepatitis B virus markers during prolonged recombinant interferon alpha-2A treatment of chronic HBV infection. J Hepatol 4: 29-36, 1987
13. Omata M, Uchiumi K: Combination of prednisolone withdrawal and antiviral agents (adenine arabinoside, interferon) in chronic hepatitis B. J Hepatol 3(suppl 2): S65-69, 1986
14. Perrillo RP: Interferon in the management of chronic hepatitis B. Dig Dis Sci 38: 577-593, 1993
15. Perrillo RP, Mason AL: Therapy for hepatitis B virus infection. Gastroenterol Clin North Am 23: 581-601, 1994
16. Perrillo RP, Regenstein FG, Bodicky CJ, Campbell CR, Sanders GE, Sunwoo YC: Comparative efficacy of adenine arabinoside 5′-monophosphate and prednisolone withdrawal followed by adenine arabinoside 5′-monophosphate in the treatment of chronic active hepatitis type B. Gastroenterology 88: 780-786, 1985
17. Perrillo RP, Regenstein FG, Peters MG, DeSchryver-Kecskemeti K, Bodicky CJ, Campbell CR, Kuhns MC: Prednisolone withdrawal followed by recombinant alfa interferon in the treatment of chronic type B hepatitis. Ann Intern Med 109: 95-100, 1988
18. Perrillo RP, Schief ER, Dans GL: A randomized, controlled trial of interferon alpha-2b alone and after prednisolone withdrawal for the treatment of chronic hepatitis B. N Engl J Med 323: 295-300, 1990
19. Ruiz-Moreno M, Camp T, Jimenez J, Lopez R, Castillo I, Bartolome J, Carreno V: Factors predictive of response to interferon therapy in children with chronic hepatitis B. J Hepatol 22: 540-544, 1995
20. Scullard GH, Smith CI, Merigan TC, Robinson WS, Gregory PB: Effects of immunosuppressive therapy on viral markers in active chronic hepatitis B. Gastroenterology 81: 987-991, 1981
21. Utili R, Sagnelli E, Gaeta GB, Galanti B, Nardiello S, Felaco F, Pasquale G: Treatment of chronic hepatitis B in children with prednisolone followed by alfa-interferon: a controlled randomized study. J Hepatol 20: 163-167, 1994
22. 2a-Interferon: A controlled, randomized study. Gastroenterology 86: 327-330, 1991
23. Vajro P, Tedesco M, Fontanella A, De Vincenzo A: Prolonged and high dose recombinant interferon alpha-2b alone or after prednisolone priming accelerates termination of active viral replication in children with chronic hepatitis B infection. Pediatr Infect Dis J 15: 223-231, 1996
24. Wu TC, Tong MJ, Hwang B, Lee SD, Hu MM: Primary hepatocellular carcinoma and hepatitis B infection during childhood. Hepatology 7: 46-48, 1987